Role Of Brm In Skin Tumour Progression From Benign To Malignant
Funder
National Health and Medical Research Council
Funding Amount
$457,267.00
Summary
Australia has the highest incidence of skin cancer in the world. Skin cancer is 3 times as common as all other cancers combined and continues to increase in incidence, particularly in the aging population. Skin cancer is caused by exposure to the ultraviolet radiation found in sunlight. Ultraviolet radiation causes the appearance of solar keratosis, or sunspots, benign lesions that are not particularly dangerous to human health. Some of these develop into malignant squamous cell carcinomas that ....Australia has the highest incidence of skin cancer in the world. Skin cancer is 3 times as common as all other cancers combined and continues to increase in incidence, particularly in the aging population. Skin cancer is caused by exposure to the ultraviolet radiation found in sunlight. Ultraviolet radiation causes the appearance of solar keratosis, or sunspots, benign lesions that are not particularly dangerous to human health. Some of these develop into malignant squamous cell carcinomas that can spread to other tissues and are potentially fatal. Little is known about the biological mechanisms involved in solar keratosis development into squamous cell carcinomas. We have identified the gene brm as being involved in this process. It has not previously been recognised that this gene is important for skin cancer development and therefore our preliminary studies have identified a potential new target. We will study the role of this gene in ultraviolet radiation induced skin carcinogenesis, determine whether it is mutated by ultraviolet radiation in human skin cancer, and what role in plays in some key biological processes in skin cancer development. This study will expand our understanding of malignant conversion during human skin carcinogenesis, the most prevalent human cancer in Australia.Read moreRead less
The University of Queensland Dermatology Research Centre are committed to conducting and promoting high quality clinical research into skin disease, particularly skin cancer, aimed at improved patient outcomes. Telemedicine and cutting edge imaging technologies are employed with a view towards their implementation into clinical practise to potentially overcome geographical inadequacies of health care in Qld. We expect the research will impact on Australian policies and guidelines in the field of ....The University of Queensland Dermatology Research Centre are committed to conducting and promoting high quality clinical research into skin disease, particularly skin cancer, aimed at improved patient outcomes. Telemedicine and cutting edge imaging technologies are employed with a view towards their implementation into clinical practise to potentially overcome geographical inadequacies of health care in Qld. We expect the research will impact on Australian policies and guidelines in the field of telemedicine and skin cancer management.Read moreRead less
Clinical Trial Of DZ13 DNAzyme Targeting C-Jun In Subjects With Basal Cell Carcinoma - DISCovery (Oligonucleotide Inhibition Of Skin Cancer) Study
Funder
National Health and Medical Research Council
Funding Amount
$74,365.00
Summary
Basal cell carcinoma (BCC) is the commonest skin cancer in Australia that is highly invasive. Surgical removal is its main treatment option but causes scarring and is impractical when there are multiple cancers. C-Jun, a molecule promoting cell growth is present in abnormally large amount in BCC compared to normal cells. Dz13 targets and destroys these molecules, killing cancer cells when injected into the tumour. Dz13 may hence become a more effective and aesthetic alternative of treating BCC.
Identification And Characterization Of A Novel Tumor Suppressor
Funder
National Health and Medical Research Council
Funding Amount
$591,997.00
Summary
Australia has the highest rate of skin cancer in the world, with over 380,000 people diagnosed every year. Of these, over 370,000 have non-melanoma skin cancers including squamous cell carcinoma and basal cell carcinoma. Our laboratory has identified a gene in mice that protects animals from squamous cell cancer. The studies proposed in this grant examine the mechanisms underpinning this protective role and may have important implications for the prevention of skin cancers in humans.